Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting
Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Bicycle Therapeutics to Present at the AACR Annual Meeting 2024
Bicycle Therapeutics to Participate in Upcoming Investor Conferences
Bicycle Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Conference
Bicycle Therapeutics Provides Data Updates for Three Clinical Programs
Bicycle Therapeutics to Host R&D Day on December 14
Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2023 Financial Results and Announces Upcoming R&D Day
CAMBRIDGE, England & BOSTON--(BUSINESS WIRE)--Oct. 30, 2023-- Bicycle Therapeutics plc (NASDAQ:BCYC), a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle®) technology, today announced that management will participate in the following investor conferences in November: